Navigation Links
Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
Date:8/10/2010

Ebersberg, Germany, August 10, 2010 Eurofins MWG Operon, international market leader and expert for custom oligonucleotide synthesis and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have signed a three year contract for the supply of synthetic DNA & RNA oligonucleotides. This long term contract builds on the relationship developed as a preferred supplier to the Medical Research Council (MRC) during the previous four years.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in; human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. By adopting a shared services approach, the Research Councils are making financial savings, and are at the same time increasing their operational efficiency.

"We are very proud that RCUK SSC Ltd has selected Eurofins MWG Operon as one of their service providers of choice, on behalf of the UK's Research Councils and continues our business relationship" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "By signing the three year contract, RCUK SSC Ltd confirms their trust in our product quality and outstanding service with which Eurofins MWG Operon has identified itself for more than twenty years."

Richard Fowles, Category Manager with RCUK SSC Ltd commented, "We are very pleased to be able to announce Eurofins MWG Operon is to be one of our preferred suppliers of oligos. We feel that their great product offering will be of significant benefit to researchers."

Eurofins MWG Operon also provides best in class next generation sequencing services, Sanger sequencing, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Eurofins MWG Operon and Genomatix launch strategic alliance
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. bioMETRX, Inc. Signs Deal To Acquire Controlling Interest in Biometric Solutions, LLC
5. Unifying the animate and the inanimate designs of nature
6. University of Miami engineer designs stretchable electronics with a twist
7. Engineering technology pinpoints earliest signs of animal life
8. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
9. UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity
10. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
11. WARF signs license agreement with Pfizer for human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)... -- Research and Markets has announced the addition of ... 2021" report to their offering. ... The biometric vehicle access system market, in ... 14.06% from 2016 to 2021. The market is estimated to be ... Million by 2021. The growth of the biometric vehicle access system ...
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the addition ... offering. The report forecasts the global military biometrics market ... The report has been prepared based on an in-depth market ... and its growth prospects over the coming years. The report also includes ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017   Pulmatrix, Inc . (NASDAQ: ... developing innovative inhaled therapies to address serious pulmonary diseases, ... infections in the lungs of CF patients, PUR1900, has ... by the U.S. Food & Drug Administration. ... to speed the development of novel drugs against important ...
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Pono ... balanced, peaceful and healthy lifestyle, announced today the official launch of its much-anticipated Pono ... the mind. , In development for over a year, the patented Pono ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, ... recently announced a collaboration with the Heidelberg University Hospital and the German Cancer ... preparation, following the company’s successful launch of its CATS (Capture and Amplification ...
Breaking Biology Technology: